Clinical Presentation and Outcomes of Hospitalized Patients with Chronic Kidney Disease and COVID-19 Variant Omicron

References

• Theofilis P, Vordoni A, Kalaitzidis RG. COVID-19 and kidney disease: a clinical perspective. Curr Vasc Pharmacol. 2022;20(4):321–325. doi:10.2174/1570161120666220513103007
   PubMed Web of Science ®Google Scholar
• Bikbov B, Purcell CA, Levey AS, GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990-2017: A systematic analysis for the global burden of disease study 2017. Lancet. 2020;395(10225):709–733. doi:10.1016/S0140-6736(20)30045-3
   PubMed Web of Science ®Google Scholar
• Chou CY, Wang SM, Liang CC, et al. Risk of pneumonia among patients with chronic kidney disease in outpatient and inpatient settings: a nationwide population-based study. Medicine. 2014;93(27):e174. doi:10.1097/MD.0000000000000174
   PubMed Web of Science ®Google Scholar
• Sarnak MJ, Jaber BL. Pulmonary infectious mortality among patients with end-stage renal disease. Chest. 2001;120(6):1883–1887. doi:10.1378/chest.120.6.1883
   PubMed Web of Science ®Google Scholar
• Clark A, Jit M, Warren-Gash C, et al. Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study. Lancet Glob Health. 2020;8(8):e1003–e1017. doi:10.1016/S2214-109X(20)30264-3
   PubMed Web of Science ®Google Scholar
• Long JD, Strohbehn I, Sawtell R, Bhattacharyya R, Sise ME. COVID-19 survival and its impact on chronic kidney disease. Transl Res. 2022;241:70–82. doi:10.1016/j.trsl.2021.11.003
   PubMed Web of Science ®Google Scholar
• Docherty AB, Harrison EM, Green CA, et al. Features of 20 133 UK patients in hospital with Covid-19 using the ISARIC WHO clinical characterisation protocol: prospective observational cohort study. BMJ Clin Res Ed. 2020;369(1985).
   PubMedGoogle Scholar
• Kizler TA, Burrowes JD, Byham-Gray LD, et al. KDOQI clinical practice guideline for nutrition in CKD: 2020 Update [published correction appears in Am. J Kidney Dis. 2020;76(3 Suppl 1):S1–S107.
   PubMed Web of Science ®Google Scholar
• Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612. doi:10.7326/0003-4819-150-9-200905050-00006
   PubMed Web of Science ®Google Scholar
• General Office of the National Health Commission. Notice on the issuance of diagnosis and treatment protocol for novel coronavirus infection; Available from: https://www.gov.cn/zhengce/zhengceku/2023-01/06/content_5735343.htm. Accessed May 16, 2024.
   Google Scholar
• Levin A, Stevens PE. Summary of recommendation statements. Kidney Int Suppl. 2013;3(1):5–14.
   Web of Science ®Google Scholar
• Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120(4):c179–c184. doi:10.1159/000339789
   PubMedGoogle Scholar
• Rabb H. Kidney diseases in the time of COVID-19: major challenges to patient care. J Clin Invest. 2020;130(6):2749–2751. doi:10.1172/JCI138871
   PubMed Web of Science ®Google Scholar
• Seidel M, Hölzer B, Appel H, Babel N, Westhoff TH, COVID Dialysis Working Group. Impact of renal disease and comorbidities on mortality in hemodialysis patients with COVID-19: a multicenter experience from Germany. J Nephrol. 2020;33(5):871–874. doi:10.1007/s40620-020-00828-8
   PubMed Web of Science ®Google Scholar
• Portolés J, Marques M, López-Sánchez P, et al. Chronic kidney disease and acute kidney injury in the COVID-19 Spanish outbreak. Nephrol Dial Transplant. 2020;35(8):1353–1361. doi:10.1093/ndt/gfaa189
   PubMed Web of Science ®Google Scholar
• Uribarri A, Núñez-Gil IJ, Aparisi A, et al. Impact of renal function on admission in COVID-19 patients: an analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID 19) Registry. J Nephrol. 2020;33(4):737–745. doi:10.1007/s40620-020-00790-5
   PubMed Web of Science ®Google Scholar
• Pilgram L, Eberwein L, Wille K, et al. Clinical course and predictive risk factors for fatal outcome of SARS-CoV-2 infection in patients with chronic kidney disease. Infection. 2021;49(4):725–737. doi:10.1007/s15010-021-01597-7
   PubMed Web of Science ®Google Scholar
• Gur E, Levy D, Topaz G, et al. Disease severity and renal outcomes of patients with chronic kidney disease infected with COVID-19. Clin Exp Nephrol. 2022;26(5):445–452. doi:10.1007/s10157-022-02180-6
   PubMed Web of Science ®Google Scholar
• Cheng Y, Luo R, Wang K, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020;97(5):829–838. doi:10.1016/j.kint.2020.03.005
   PubMed Web of Science ®Google Scholar
• Shukla AK, Banerjee M. Angiotensin-converting-enzyme 2 and renin-angiotensin system inhibitors in COVID-19: an update. High Blood Press Cardiovasc Prev. 2021;28(2):129–139. doi:10.1007/s40292-021-00439-9
   PubMed Web of Science ®Google Scholar
• Alshahawey M, Raslan M, Sabri N. Sex-mediated effects of ACE2 and TMPRSS2 on the incidence and severity of COVID-19; The need for genetic implementation. Curr Res Transl Med. 2020;68(4):149–150. doi:10.1016/j.retram.2020.08.002
   PubMed Web of Science ®Google Scholar
• Jin JM, Bai P, He W, et al. Gender differences in patients with COVID-19: focus on severity and mortality. Front Public Health. 2020;8:152. doi:10.3389/fpubh.2020.00152
   PubMed Web of Science ®Google Scholar
• Shouman K, Vanichkachorn G, Cheshire WP, et al. Autonomic dysfunction following COVID-19 infection: an early experience. Clin Auton Res. 2021;31(3):385–394. doi:10.1007/s10286-021-00803-8
   PubMed Web of Science ®Google Scholar
• Vanoli J, Marro G, Dell’Oro R, et al. Elevated resting heart rate as independent in-hospital prognostic marker in COVID-19. Cardiol J. 2022;29(2):181–187. doi:10.5603/CJ.a2022.0009
   PubMed Web of Science ®Google Scholar
• Liu W, Tao ZW, Wang L, et al. Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease. Chin Med J (Engl). 2020;133(9):1032–1038. doi:10.1097/CM9.0000000000000775
   PubMed Web of Science ®Google Scholar
• Ora J, Liguori C, Puxeddu E, et al. Dyspnea perception and neurological symptoms in non-severe COVID-19 patients. Neurol Sci. 2020;41(10):2671–2674. doi:10.1007/s10072-020-04632-x
   PubMed Web of Science ®Google Scholar
• Simonson TS, Baker TL, Banzett RB, et al. Silent hypoxaemia in COVID-19 patients. J Physiol. 2021;599(4):1057–1065. doi:10.1113/JP280769
   PubMed Web of Science ®Google Scholar
• Shi L, Wang Y, Wang Y, Duan G, Yang H. Dyspnea rather than fever is a risk factor for predicting mortality in patients with COVID-19. J Infect. 2020;81(4):647–679. doi:10.1016/j.jinf.2020.05.013
   PubMed Web of Science ®Google Scholar
• Li Y, Yang T, Wang S, et al. The value of lymphocyte count in determining the severity of COVID-19 and estimating the time for nucleic acid test results to turn negative. Bosnian J Basic Med Sci. 2021;21(2):235–241.
   PubMed Web of Science ®Google Scholar
• Ahmadian E, Hosseiniyan Khatibi SM, Razi Soofiyani S, et al. Covid-19 and kidney injury: pathophysiology and molecular mechanisms. Rev Med Virol. 2021;31(3):e2176. doi:10.1002/rmv.2176
   PubMed Web of Science ®Google Scholar
• Henry BM, De Oliveira MHS, Benoit S, Plebani M, Lippi G. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chem Lab Med. 2020;58(7):1021–1028. doi:10.1515/cclm-2020-0369
   PubMed Web of Science ®Google Scholar
• Fajgenbaum DC, June CH, Longo DL. Cytokine storm. N Engl J Med. 2020;383(23):2255–2273. doi:10.1056/NEJMra2026131
   PubMed Web of Science ®Google Scholar
• Wolff D, Nee S, Hickey NS, Marschollek M. Risk factors for Covid-19 severity and fatality: a structured literature review. Infection. 2021;49(1):15–28. doi:10.1007/s15010-020-01509-1
   PubMed Web of Science ®Google Scholar
• Zheng Z, Peng F, Xu B, et al. Risk factors of critical and mortal COVID-19 cases: a systematic literature review and meta-analysis. J Infect. 2020;81(2):e16–e25. doi:10.1016/j.jinf.2020.04.021
   PubMed Web of Science ®Google Scholar
• Zinellu A, Paliogiannis P, Carru C, Mangoni AA. INR and COVID-19 severity and mortality: a systematic review with meta-analysis and meta-regression. Adv Med Sci. 2021;66(2):372–380. doi:10.1016/j.advms.2021.07.009
   PubMed Web of Science ®Google Scholar
• Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3. JAMA. 2016;315(8):801–810. doi:10.1001/jama.2016.0287
   PubMed Web of Science ®Google Scholar
• Zhou XY, Ben SQ, Chen HL. A comparison of Apache II and CPIS scores for the prediction of 30-day mortality in patients with ventilator-associated pneumonia. Int J Infect Dis IJID off Publ Int Soc Infect Dis. 2015;30:144–147.
   PubMed Web of Science ®Google Scholar
• ZJ L, Subramaniam A, Ponnapa RM, et al. Case fatality rates for patients with COVID-19 requiring invasive mechanical ventilation. A meta-analysis. Am J Respir Crit Care Med. 2021;203(1):54–66. doi:10.1164/rccm.202006-2405OC
   PubMed Web of Science ®Google Scholar